#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primitive neuroectodermal tumour Cluster headache Erythema multiforme Chronic cutaneous lupus erythematosus Transferrin decreased Alveolar rhabdomyosarcoma Mastocytosis Oesophageal adenocarcinoma stage III Mitochondrial DNA depletion Cortical dysplasia Bone marrow disorder Epstein-Barr virus infection Human papilloma virus immunisation Leukodystrophy Prostate cancer More trials…

    Learn about Rare Diseases

    Burkitt’s lymphoma – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Trials in Disease Chondrosarcoma – Treatment Idiopathic inflammatory myopathy – Basic Information Synovial sarcoma metastatic – Trials in Disease Krabbe’s disease – Trials in Disease Cytokine release syndrome Angiosarcoma metastatic – Diagnostics Retinoblastoma – Treatment Cystic fibrosis lung More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Somapacitan Tiragolumab Tinengotinib TEDUGLUTIDE Folinic Acid Tamoxifen Epoetin Alfa Gd2Il18Cart Msv-Allo Human Normal Immunoglobulin Amisulpride Daunorubicin ULEFNERSEN Deucrictibant Sotalol Hydrochloride Nedosiran VHB937 Posenacaftor Estradiol Valerate Ubiquinol More therapies…

    Learn about Your Condition

    Marfan's syndrome Rectal cancer stage II Adrenal insufficiency Hodgkin's disease refractory Naevoid melanoma Type V hyperlipidaemia Hepatorenal syndrome Colon cancer metastatic Keratosis follicular Colon cancer Graft infection Herpes virus infection Anal cancer stage III Schizophreniform disorder Usher's syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Brive

Centre Hospitalier De Brive

1 Boulevard Du Docteur Verlhac, Brive La Gaillarde, 19100, France

Want to learn more about this study or check if you can participate? Contact us.

  • A study testing how well AZD4144 works and how safe it is for adults with acute kidney injury caused by sepsis

    Recruiting

    2 1
    Investigated Diseases:
    • Acute kidney injury
    Belgium Czechia Denmark France Germany Greece +3

  • Study on Esmolol Hydrochloride vs. Sufentanil Citrate for Recovery Quality in Patients Undergoing Laparoscopic Gallbladder Surgery with Anesthesia

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Esmolol Hydrochloride
    • Sufentanil Citrate
    France

  • Study on Preventing Infections in ICU Patients with Interferon Gamma and Sodium Chloride

    Recruiting

    3 1 1
    Investigated Drugs:
    • Recombinant Human Interferon Gamma 1B
    • Sodium Chloride
    France

  • Study Comparing Dalbavancin to Standard Antibiotics for Patients with Staphylococcus aureus Bloodstream Infections

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • CEFTAROLINE FOSAMIL
    • Delafloxacin
    • Lymecycline
    France

  • Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ciprofloxacin Hydrochloride
    • Ciprofloxacin
    • Clavulanic Acid
    France

  • Study on Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Patients: Comparing Dasatinib, Imatinib, Nilotinib, and Bosutinib Strategies

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic myeloid leukaemia
    Investigated Drugs:
    • Imatinib
    • Bosutinib
    • Dasatinib
    France

  • Study on Dobutamine and Glucose for Patients with Septic Cardiomyopathy and Low Blood Flow

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Dobutamine Hydrochloride
    • Glucose Monohydrate
    France

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!